SOPHARMA: strona spółki
30.03.2026, 10:08
SPH Publishing of Annual individual audited financial statement for 2025
Sofia, Bulgaria, 30 March 2026 – According to the requirements of art. 100n of LPOS, “Sopharma” AD (SFA: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) presents the Annual Audited Individual Financial Statements, which contains:
• XHTML format of the report in accordance with the requirements of Commission Delegated Regulation (EU) 2018/815 of 17 December 2018 supplementing Directive 2004/109/EC of the European Parliament and of the Council with regulatory technical standards on the definition of a common electronic format for reports. It contains: - Annual financial statements according to IFRS; - Notes to the annual financial statements; - Annual management report and non-financial declaration; - Corporate governance Declaration; - Report on the implementation of the remuneration policy; - Declaration by the responsible persons; - Audit report; and - Audit declaration. • Annual reports according to a template determined by the Deputy Chairman of the Financial Supervision Commision; • Corporate Governance Scorecard; • Electronic reference to the published inside information under Article 7 of Regulation (EU) №596 / 2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC (OJ L 173/1 of 12 June 2014) (Regulation (EU) № 596/2014) on the circumstances during the past year: http://www.x3news.com/?page=News&uniqid=6242d3eba9dc7 https://www.sopharmagroup.com/en/home/investors/investor-news/public-disclosure-of-inside-information-in-compliance-with-article-17-of-regulation-eu-no-596-2014-on-market-abuse
• XHTML format of the report in accordance with the requirements of Commission Delegated Regulation (EU) 2018/815 of 17 December 2018 supplementing Directive 2004/109/EC of the European Parliament and of the Council with regulatory technical standards on the definition of a common electronic format for reports. It contains: - Annual financial statements according to IFRS; - Notes to the annual financial statements; - Annual management report and non-financial declaration; - Corporate governance Declaration; - Report on the implementation of the remuneration policy; - Declaration by the responsible persons; - Audit report; and - Audit declaration. • Annual reports according to a template determined by the Deputy Chairman of the Financial Supervision Commision; • Corporate Governance Scorecard; • Electronic reference to the published inside information under Article 7 of Regulation (EU) №596 / 2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC (OJ L 173/1 of 12 June 2014) (Regulation (EU) № 596/2014) on the circumstances during the past year: http://www.x3news.com/?page=News&uniqid=6242d3eba9dc7 https://www.sopharmagroup.com/en/home/investors/investor-news/public-disclosure-of-inside-information-in-compliance-with-article-17-of-regulation-eu-no-596-2014-on-market-abuse